CMV infection may weaken immune responses in kidney transplant patients
NCT ID NCT06976008
First seen Sep 30, 2025 · Last updated Jun 20, 2026 · Updated 29 times
Summary
This study looks at how cytomegalovirus (CMV) infection changes the immune system's ability to fight other infections in kidney transplant patients. Researchers will take blood samples from 60 participants, both before and after CMV infection, to measure immune cell responses. The goal is to understand which immune pathways are disrupted, which could lead to better infection management in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Necker-Enfants Malades
Paris, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Hôpital européen Georges Pompidou
Paris, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Insitut Pasteur
Paris, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better manage infections in kidney transplant patients by understanding how CMV alters immunity.
What could go wrong
This is an observational study with only 60 participants, so results may not apply to all patients. It does not test a new treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.